» Articles » PMID: 30815610

Oropharyngeal Candidiasis in HIV/AIDS Patients and Non-HIV Subjects in the Southeast of Iran

Overview
Journal Curr Med Mycol
Date 2019 Mar 1
PMID 30815610
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: species are the common opportunistic pathogens during the course of human immunodeficiency virus (HIV) infection. Oropharyngeal candidiasis (OPC) is generally known as the initial sign of HIV infection. The aim of this study was to compare demographic characteristics and frequency of species between HIV/AIDS patients and non-HIV subjects in Kerman, southeast of Iran.

Materials And Methods: This study was conducted on 143 samples collected from the oral cavity of 81 HIV/AIDS patients and 35 non-HIV subjects. The samples were cultured on Sabouraud dextrose agar and CHROMagar. The identification of species was accomplished using the color of colony and polymerase chain reaction-restriction fragment length polymorphism.

Results: According to the results, C. albicans (n=25, 69.14%) was the most prevalent species isolated from the HIV/AIDS patients, followed by C. glabrata (n=19, 23.46%). Other isolated species included (n=4, 4.94 %), (n=1, 1.24%), and (n=1, 1.24%). Out of the 35 species recovered from the oral samples of non-HIV subjects, 23 (65.71%) and 12 (34.29%) cases were and , respectively. was the only non- species found in the non-HIV subjects that was also the predominant isolated species. Regarding the HIV/AIDS patients, the highest prevalence of OPC was observed in the age group of 41-50 years. However, in the non-HIV subjects, the age group of 31-40 years had the highest prevalence of this infection. Furthermore, no correlation was observed between the gender and number of isolates.

Conclusion: Consideration of the epidemiologic data showed that the two groups were significantly different in terms of the prevalence of species, which could play a major role in the selection of effective drugs for the treatment of candidiasis.

Citing Articles

Distribution of Candida species isolated from people living with human immunodeficiency virus with oropharyngeal and oral candidiasis in Africa in the era of universal test and treat policy: a systematic review and meta-analysis.

Musinguzi B, Obuku E, Mwesigwa A, Migisha R, Kinengyere A, Ndagire R Trop Med Health. 2024; 52(1):88.

PMID: 39593167 PMC: 11600869. DOI: 10.1186/s41182-024-00649-6.


Prevalence of Oropharyngeal Candidiasis and distribution of species among People Living with Human Immunodeficiency Virus in Africa: a systematic review and meta-analysis.

Musinguzi B, Obuku E, Kinengyere A, Ndagire R, Baguma A, Mwesigwa A Res Sq. 2024; .

PMID: 38883750 PMC: 11177986. DOI: 10.21203/rs.3.rs-4534730/v1.


Molecular identification and antifungal susceptibility profiles of etiologic agents of oral candidiasis among HIV-positive patients: A multicenter study.

Morovati H, Jokari M, Eslami S, Zomorodian K, Taeri K, Khalaf N Curr Med Mycol. 2024; 9(2):10-16.

PMID: 38375522 PMC: 10874477. DOI: 10.18502/CMM.2023.345058.1414.


The Association Between Oral Mucosal Lesions and Oral Health-Related Quality of Life Using the Validated Indonesian Version of OHIP-14 Among People Living with HIV/AIDS.

Sufiawati I, Amalia T, Dewi T, Wisaksana R HIV AIDS (Auckl). 2024; 16:9-16.

PMID: 38348377 PMC: 10860594. DOI: 10.2147/HIV.S452154.


Molecular Detection of Secreted Aspartyl Proteinases (Saps) From Dental Isolates of Candida albicans and Targeting With Psidium guajava Biocompounds: An In Vitro and In Silico Analysis.

Safiya S N, Smiline Girija A, Priyadharsini V Cureus. 2023; 15(11):e49143.

PMID: 38130563 PMC: 10733579. DOI: 10.7759/cureus.49143.


References
1.
Berenji F, Zabolinejad N, Badiei Z, Kakhi S, Andalib Aliabadi Z, Ganjbakhsh M . Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran. Curr Med Mycol. 2017; 1(4):33-36. PMC: 5490279. DOI: 10.18869/acadpub.cmm.1.4.33. View

2.
Adedigba M, Ogunbodede E, Jeboda S, Naidoo S . Patterns of oral manifestation of HIV/AIDS among 225 Nigerian patients. Oral Dis. 2008; 14(4):341-6. DOI: 10.1111/j.1601-0825.2007.01384.x. View

3.
Ribeiro A, Menezes T, de Melo Alves-Junior S, de Menezes S, Marques-da-Silva S, Vallinoto A . Oral carriage of Candida species in HIV-infected patients during highly active antiretroviral therapy (HAART) in Belém, Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120(1):29-33. DOI: 10.1016/j.oooo.2015.03.008. View

4.
Li Y, Chen W, Li X, Li H, Li H, Wang L . Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infect Dis. 2013; 13:46. PMC: 3641955. DOI: 10.1186/1471-2334-13-46. View

5.
Anwar K, Malik A, Subhan K . Profile of candidiasis in HIV infected patients. Iran J Microbiol. 2012; 4(4):204-9. PMC: 3507311. View